Anti-obesity drug therapy can be offered as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial body mass index (BMI) of 30 kg/m 2 or 2730 kg/m 2 in the presence of at least one weight-related comorbidity, e.g., dysglycemia, hypertension, dyslipidemia, or obstructive sleep apnea
As a result many clinicians who prescribe them question their sustainability
These prescription medications mimic a natural hormone your body produces to control hunger and metabolism
Were excited to introduce our groundbreaking GLP-1 Longevity Wellness Program, featuring precision microdosing of tirzepatidea cutting-edge approach designed not just for weight loss, but for optimizing your metabolic health and extending your healthspan
Frias JP, Hsia S, Eyde S, Liu R, Ma X, Konig M, et al